Robert A. Figlin on Muck Rack

Robert A. Figlin

Los Angeles
As seen in: Oncology News Central, Frontiers, Biomed Central (BMC), AACR Journal, MedCentral, ONCOLOGY journal, The ASCO Post, OncLive, Targeted Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

“Not a Straightforward Decision”: What to Do While Waiting on a Practice Change in Breast Cancer Care

|
By Marla Lipsyc-Sharf, Robert A. Figlin
| Oncology News Central
In the wake of recent key data about ESR1-mutated metastatic breast cancer, treatment decisions have become more complicated. “In current clinical practice, this is not a straightforward decision. We’re not exactly sure how to incorporate these findings,” explains Marla Lipsyc-Sharf, MD, assistant professor at UCLA Health’s Jonsson Comprehensive Cancer Center in Los Angeles. She discusses how oncologists are approaching therapy choices while awaiting big potential changes with Robert A.
Open in Who Shared Issue with article?

New Targeted Therapies Make Breast Cancer Treatment Decisions “a Bit of a Moving Target”

|
By Hope Rugo, Robert A. Figlin
| Oncology News Central
“In breast cancer now, all of our treatment for hormone receptor–positive metastatic disease is a bit of a moving target because of new therapies that are available,” explains Hope S. Rugo, MD, division chief of breast medical oncology and the Women’s Cancers Program director at the City of Hope Comprehensive Cancer Center in Duarte, California. She discusses the “ever-changing” landscape involving the PI3 kinase/AKT/mTOR pathway with Robert A.
Open in Who Shared Issue with article?

Advances in ESR1-Mutated Breast Cancer Care Lead to “Complex Situation” in Clinic

|
By Hope Rugo, Robert A. Figlin
| Oncology News Central
As the management of patients with ESR1-mutated metastatic breast cancer evolves, various questions have emerged in clinical practice. “It’s a complex situation,” explains Hope S. Rugo, MD, division chief of breast medical oncology and the Women’s Cancers Program director at the City of Hope Comprehensive Cancer Center in Duarte, California. She discusses how recent advances have changed treatment decisions with Robert A.
Open in Who Shared Issue with article?
See all 65 licensed articles (77 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified